Theratechnologies Inc. (TSE:TH - Get Free Report) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$2.25 and traded as high as C$2.52. Theratechnologies shares last traded at C$2.47, with a volume of 25,800 shares.
Theratechnologies Price Performance
The company has a market capitalization of C$114.03 million, a P/E ratio of -13.78, a P/E/G ratio of -8.50 and a beta of 1.73. The business's 50-day simple moving average is C$2.27 and its 200 day simple moving average is C$1.97. The company has a current ratio of 1.10, a quick ratio of 0.64 and a debt-to-equity ratio of 562.07.
About Theratechnologies
(
Get Free Report)
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
See Also
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
